Archivo

Entradas Etiquetadas ‘medicamento’

Supplying a pharmacy for NASA Exploration SpaceFlight

In order to maintain crew health and performance during long-duration spaceflight outside of low-Earth orbit, NASA and its international partners must be capable of providing a safe and effectivepharmacy. Given few directed studies of pharmaceuticals in the space environment, it is difficult to characterize pharmaceutical effectiveness or stability during spaceflight; this in turn makes it challenging to select an appropriate formulary for exploration. Here, we present the current state of literature regarding pharmaceutical stability, metabolism, and effectiveness during spaceflight. In particular, we have attempted to highlight the gaps in current knowledge and the difficulties in translating terrestrial-based drug studies to a meaningful interpretation of drug stability, safety, and effectiveness in space. We hope to identify high-yield opportunities for future research that might better define and mitigate pharmaceutical risk for exploration missions

Supplying a pharmacy for NASA exploration spaceflight: challenges and current understanding

Rebecca S. Blue , Tina M. Bayuse, Vernie R. Daniels , Virginia E. Wotring , Rahul Suresh , Robert A. Mulcahy and Erik L. Antonsen

npj Microgravity (2019) 5:14 ;

https://doi.org/10.1038/s41526-019-0075-2

El consumo de Opioides en Espa√Īa se incrementa casi al doble en los √ļltimos a√Īos

Lunes, 18 de marzo de 2019 Twitter Sin comentarios

La Agencia Espa√Īola de Medicamentos y Productos Sanitarios (AEMPS) ha publicado el informe de utilizaci√≥n de Opioides en Espa√Īa durante el periodo 2010-2017. En primera posici√≥n del ranking de consumo, se sit√ļa el¬†tramadol y paracetamol, con un¬†34,84¬† por ciento . En segunda posici√≥n, con un 22,53 por ciento, el tramadol; le sigue el fentanilo, con un 16,28 por ciento; code√≠na y paracetamol, con un 10,59 por ciento; buprenofina, con un 6,1 por ciento; tapentadol, con 2,9 por ciento; oxicodona y naloxona, 2,6 por ciento; tramadol y dexketoprofeno, 1,68 por ciento; code√≠na e ibuprofeno, 1,6 por ciento; y,¬†la morfina, completa el top 10, con un consumo del 1,85 por ciento.

Si quieres leer el informe completo:

Informe AEMPS de utilizaci√≥n de Opioides en Espa√Īa 2010-2017

Lista medicamentos excluidos de la Seguridad Social

Jueves, 5 de julio de 2012 Luis Cotarelo 1 comentario

El Ministerio de Sanidad, Servicios Sociales e Igualdad ha publicado en su página web la lista de los medicamentos que quedan excluidos de la prestación farmacéutica de la Seguridad Social . Medicamentos tan conocidos como Almax, Fortasec, Voltaren u Omeprazol son algunos de los 426 fármacos que, a partir de ahora, los usuarios de la Seguridad Social deberán pagar de forma íntegra. Así mismo en el enlace del Ministerio tienes toda la información sobre el nuevo sistema de aportación de los usuarios en la prestación farmaceutica ambulatoria.

 

**Listado medicamentos excluidos de prestación farmaceutica de la Seguridad Social Junio 2012

Categories: General, Legal Tags: , ,

Drugs and Alcohol in Civil General Aviation Accident Pilot Fatalities 2004-2008

Jueves, 29 de septiembre de 2011 Estrella Forster Sin comentarios

The data for this study was from 1353 pilots who died from 2004 to 2008, most from general aviation accidents. The majority of the pilots held a third-class medical certicate. Drugs or medications were found from 42% of pilots tested, being Diphenhydramine (an H1 antihistimine with impairing properties) the most common. The FAA has taken steps to warn pilots of the dangers in using this medication that can be dispensed as both a prescription and over the counter. A 7% of pilots were found alcohol levels above FAA limit. Interesting thecnical report advisable for the AME’s -aviation medical examiners- who issue medical certicates for priveta pilots

 

** Drugs and Alcohol in Civil Aviation Accident Pilot Fatalities From 2004-2008

      DOT/FAA/AM-11/13. Office of Aerospace Medicine. Washington, DC 20591

      Canfield,D.;Dubowski,K;Chaturvedi,A and Whinnery,J.

      Civil Aeromedical Institute (CAMI)- Oklahoma City, OK     -September 2011-

      

FAA Changes Policy on Antidepressants for Pilots

FAA will allow some pilots to fly while taking one of four approved medications for mild to moderate depression, provided they have been stable on the medication¬†.On a case-by-case basis beginning April 5, pilots who take one of four antidepressant medications ‚Äď Fluoxetine (Prozac), Sertraline (Zoloft), Citalopram (Celexa), or Escitalopram (Lexapro) ‚Äď will be allowed to fly if they have been satisfactorily treated on the medication for at least 12 months.The FAA‚Äôs policy is consistent with recommendations from the Aerospace Medical Association, Aircraft Owners and Pilots Association, Air Line Pilots Association and the International Civil Aviation Organization.

 

** FAA Proposes New Policy on Antidepressants for Pilots

** FAA Policy on Antidepressants: Questions and Answers